PneumRx develops minimally invasive medical devices, seeking to meet the market need for better, minimally invasive treatments for emphysema patients. The company’s innovative implantable device, the RePneu® Lung Volume Reduction Coil (LVRC™), is an investigational device designed to improve lung function in patients with emphysema by reducing lung volume using minimally invasive means. Improvement in lung function is often felt within hours after the procedure and patients generally continue to improve in pulmonary function, physical endurance and activities of daily living over several months post procedure. The RePneu LVRC, not yet available commercially, is currently undergoing human clinical trials that have shown the RePneu LVRC device and procedure to be well-tolerated, with no unanticipated adverse events experienced by any of the clinical trial patients.

back to the top